Insider Trading History of Shirahama Norio Seijiro

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Shirahama Norio Seijiro since 2006. The trader's CIK number is 1205385. At the time of the last reporting, Shirahama Norio Seijiro was the President - Asia Pac of Plus Therapeutics, Inc.. (stock ticker symbol PSTV). Also see all insider trading activities at Plus Therapeutics, Inc..

Note that in the past SHIRAHAMA NORIO SEIJIRO also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Cova Investment Advisory Corp (CYTX) by Shirahama Norio Seijiro

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 CYTX 1,100 $4,587 0 $0 0 $0

Yearly summary of insider trading at Plus Therapeutics, Inc. (CYTX) by Shirahama Norio Seijiro

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 CYTX 1,500 $6,855 0 $0 0 $0
2008 CYTX 2,500 $4,800 0 $0 0 $0
2006 CYTX 4,200 $18,223 0 $0 0 $0


Insider trading activities at 2 companies by Shirahama Norio Seijiro:

1. Cova Investment Advisory Corp (CYTX)

2. Plus Therapeutics, Inc. (CYTX)

Table 1. Insider trading of Cova Investment Advisory Corp (CYTX) by Shirahama Norio Seijiro

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-08-23 CYTX Buy 1,100 4.17 4,587

Table 2. Insider trading of Plus Therapeutics, Inc. (CYTX) by Shirahama Norio Seijiro

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-06-04 CYTX Buy 1,500 4.57 6,855
2008-11-26 CYTX Buy 2,500 1.92 4,800
2006-11-21 CYTX Buy 2,000 4.20 8,400
2006-08-23 CYTX Buy 1,100 4.17 4,587
2006-08-21 CYTX Buy 1,100 4.76 5,236

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shirahama Norio Seijiro (President - Asia Pac of Plus Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.